Home / Markets
Wednesday, January 07, 2009
Wyeth in Talks to Buy Crucell
Associated Press
NEW YORK--Dutch vaccine maker Crucell (CRXL) says it is in acquisition talks with drugmaker Wyeth (WYE). Crucell NV says the talks are at preliminary stages.
The statement comes shortly after a Wall Street Journal report saying Wyeth was in talks to buy Crucell for up to $1.35 billion.
A spokesman for Madison, New Jersey-based Wyeth says the company does not comment on market speculation.
The report, published on the newspaper's Web site Wednesday and attributed to unnamed sources, comes hours after Wyeth Chief
Executive and Chairman Bernard Poussot told analysts at an investment conference that he believes "the only way forward for
the pharmaceutical industry is to get into biotechnology."
Fox Business Video
-
-
The Business of Sports
-
Nov 7, 2009
FOXBusiness.com LIVE
-
-
-
Jim Caviezel: Hollywood and th...
-
Nov 7, 2009
Actor in life in film
-
-
-
Ticker Tape Parade Invades Downtown
-
Nov 7, 2009
Yankees celebrate 27th World Series win
-
-
-
Cavuto Business Report 11-06-09
-
Nov 7, 2009
Business Report: Cavuto
-
-
-
Pro Poker Player: $2M in 2 Months
-
Nov 7, 2009
Pro Poker player on growing success of sport
-
